Since Mallinckrodt purchased the drug from Questcor in 2014, the price of Acthar has gone from $32,000 a vial to nearly $39,000. In 2000, before Questcor purchased it, it was $40. Questcor shocked the medical community when, on August 27, 2007, it raised the price overnight from $1,600 to $23,000 a vial.
Last year, Mallinckrodt paid $100 million without admitting liability to settle a lawsuit by the Federal Trade Commission and five states stemming from Questcor’s purchase of a competitor drug that the FTC said “threatened its monopoly.” (CNN)